ASND
Ascendis Pharma A/SHealthcare$229.25
▲ Bullish
Mkt Cap: $14.07B|Float: 60.9M|SI: 6.3%|DTC: 5.2
Data as of market close Apr 2, 2026
IV Rank
85
IV Pctl
78%
HV 20d
3196.0%
52W Range
$124-$249
ATR(14)
$8.19
Exp. Move
±7.0%
P/C Ratio
0.13
Earnings
Apr 30
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Below
Exp. Move Wide
Low Put/Call
ASND Key Options Data
- IV Rank
- 85.3%
- Total GEX
- $0.00B
- Total DEX
- $0.5M
- Max Pain
- $220.00
- Expected Move
- ±7.0%
- Put/Call OI
- 0.13
- Net Premium
- $1.3M
- Spot Price
- $229.25
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$16.10 | ±7.0% | $213.15 | $245.35 |
| 2026-05-15 | 43 | ±$31.70 | ±13.8% | $197.55 | $260.95 |
| 2026-06-18 | 77 | ±$39.30 | ±17.1% | $189.95 | $268.55 |
| 2026-07-17 | 106 | ±$33.15 | ±14.5% | $196.10 | $262.40 |
| 2026-08-21 | 141 | ±$51.70 | ±22.6% | $177.55 | $280.95 |
| 2026-10-16 | 197 | ±$27.80 | ±12.1% | $201.45 | $257.05 |
Explore ASND options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.